Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes
- PMID: 11915023
- DOI: 10.1053/jhep.2002.32533
Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes
Abstract
The mechanisms by which bile acids induce apoptosis in hepatocytes and the signaling pathways involved in the control of cell death are not understood fully. Here, we examined the impact of mitogen-activated protein kinase (MAPK) and phosphatidyl inositol 3-kinase (PI3K) signaling on the survival of primary hepatocytes exposed to bile acids. Treatment of hepatocytes with deoxycholic acid (DCA), chenodeoxycholic acid (CDCA) or ursodeoxycholic acid (UDCA) caused sustained MAPK activation that was dependent on activation of the epidermal growth factor receptor (EGFR). Activation of MAPK was partially blocked by inhibitors of PI3K. Inhibition of DCA-, CDCA-, and UDCA-stimulated MAPK activation resulted in approximately 20%, approximately 35%, and approximately 55% apoptosis, respectively. The potentiation of DCA- and CDCA-induced apoptosis by MEK1/2 inhibitors correlated with cleavage of procaspase 3, which was blocked by inhibitors of caspase 8 (ile-Glu-Thr-Asp-p-nitroanilide [IETD]) and caspase 3 (DEVD). In contrast, the potentiation of UDCA-induced apoptosis weakly correlated with procaspase 3 cleavage, yet this effect was also blocked by IETD and DEVD. Incubation of hepatocytes with the serine protease inhibitor AEBSF reduced the death response of cells treated with UDCA and MEK1/2 inhibitor to that observed for DCA and MEK1/2 inhibitor. The apoptotic response was FAS receptor- and neutral sphingomyelinase-dependent and independent of FAS ligand expression, and neither chelation of intracellular and extracellular Ca(2+) nor down-regulation of PKC expression altered the apoptotic effects of bile acids. In conclusion, bile acid apoptosis is dependent on the production of ceramide and is counteracted by activation of the MAPK and PI3K pathways.
Comment in
-
Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways.Hepatology. 2002 Apr;35(4):971-3. doi: 10.1053/jhep.2002.32931. Hepatology. 2002. PMID: 11915048 Review. No abstract available.
Similar articles
-
Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53.Hepatology. 2002 Jul;36(1):39-48. doi: 10.1053/jhep.2002.33899. Hepatology. 2002. PMID: 12085347
-
Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.Mol Biol Cell. 2001 Sep;12(9):2629-45. doi: 10.1091/mbc.12.9.2629. Mol Biol Cell. 2001. PMID: 11553704 Free PMC article.
-
Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.Hepatology. 2004 Jun;39(6):1563-73. doi: 10.1002/hep.20246. Hepatology. 2004. PMID: 15185297
-
Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer.Dig Dis Sci. 2014 Oct;59(10):2367-80. doi: 10.1007/s10620-014-3190-7. Epub 2014 Jun 11. Dig Dis Sci. 2014. PMID: 25027205 Free PMC article. Review.
-
[Clinical pharmacology of ursodeoxycholic acid (UDCA)].Postepy Hig Med Dosw. 1994;48(1):53-68. Postepy Hig Med Dosw. 1994. PMID: 8058580 Review. Polish.
Cited by
-
Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.J Mol Med (Berl). 2017 Jan;95(1):109-117. doi: 10.1007/s00109-016-1462-8. Epub 2016 Aug 27. J Mol Med (Berl). 2017. PMID: 27568040 Free PMC article.
-
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.Am J Pathol. 2006 Feb;168(2):398-409. doi: 10.2353/ajpath.2006.050126. Am J Pathol. 2006. PMID: 16436655 Free PMC article.
-
Bile acids for primary sclerosing cholangitis.Cochrane Database Syst Rev. 2011 Jan 19;2011(1):CD003626. doi: 10.1002/14651858.CD003626.pub2. Cochrane Database Syst Rev. 2011. PMID: 21249655 Free PMC article. Review.
-
Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.Hepatology. 2012 Jan;55(1):267-76. doi: 10.1002/hep.24681. Epub 2011 Nov 30. Hepatology. 2012. PMID: 21932398 Free PMC article.
-
Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth.Dig Liver Dis. 2009 Jul;41(7):523-33. doi: 10.1016/j.dld.2008.09.011. Epub 2008 Oct 22. Dig Liver Dis. 2009. PMID: 18948067 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous